SuperworthRelay Therapeutics shares outstanding RLAY
Diluted shares outstanding, averaged over each quarter, from 2019.
- Latest quarter, to Jun 30, 2026
- 202.8M
- On a year earlier
- +18.4%
- more shares
Relay Therapeutics had 202.8M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 18.4% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 173.4M | +4% |
| FY2024 | 167.3M | +34% |
| FY2023 | 124.8M | +3% |
| FY2022 | 121M | +18% |
| FY2021 | 102.7M | +14% |
| FY2020 | 89.8M | +2247% |
| FY2019 | 3.8M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 202.8M | +18% | |
| Q1 FY26 | 179.8M | +6% | |
| Q4 FY25 | 173.4M | +4% | |
| Q3 FY25 | 172.4M | +23% | |
| Q2 FY25 | 171.3M | +29% | |
| Q1 FY25 | 169.2M | +29% | |
| Q4 FY24 | 167.3M | +34% | |
| Q3 FY24 | 140.2M | +15% | |
| Q2 FY24 | 132.8M | +9% | |
| Q1 FY24 | 130.8M | +8% | |
| Q4 FY23 | 124.8M | +3% | |
| Q3 FY23 | 122.2M | +10% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Relay Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.